Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
50.82B
Market cap50.82B
Price-Earnings ratio
20.03
Price-Earnings ratio20.03
Dividend yield
0.88%
Dividend yield0.88%
Average volume
2.40M
Average volume2.40M
High today
$266.38
High today$266.38
Low today
$253.28
Low today$253.28
Open price
$255.32
Open price$255.32
Volume
2.66M
Volume2.66M
52 Week high
$377.54
52 Week high$377.54
52 Week low
$244.82
52 Week low$244.82

Stock Snapshot

As of today, Cencora, Inc.(COR) shares are valued at $261.08. The company's market cap stands at 50.82B, with a P/E ratio of 20.03 and a dividend yield of 88.1%.

As of 2026-05-10, Cencora, Inc.(COR) stock has fluctuated between $253.28 and $266.38. The current price stands at $261.08, placing the stock +3.1% above today's low and -2.0% off the high.

Cencora, Inc.(COR) shares are trading with a volume of 2.66M, against a daily average of 2.4M.

In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $244.82.

In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $244.82.

COR News

Simply Wall St 23h
Can Cencora Sustain Its Margin Gains While Accepting Slower Revenue Growth?

Cencora, Inc. has already reported fiscal 2026 second-quarter results, posting sales of US$78.36 billion and net income of US$1.64 billion, while slightly raisi...

Can Cencora Sustain Its Margin Gains While Accepting Slower Revenue Growth?
TipRanks 2d
Cencora price target lowered to $342 from $400 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Cencora (COR) to $342 from $400 and keeps an Overweight rating on the shares. Unlock hedge fund-level data an...

Nasdaq 4d
Cencora Q2 2026 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Cencora Q2 2026 Earnings Transcript

Analyst ratings

82%

of 17 ratings
Buy
82.4%
Hold
17.6%
Sell
0%

More COR News

Seeking Alpha 4d
Cencora hits 52-week low after guidance cut

Cencora (COR) shares reached a 52-week low on Wednesday after the medical distributor missed Street forecasts with its Q2 fiscal 2026 results and lowered its fu...

Cencora hits 52-week low after guidance cut
TipRanks 4d
Cencora lifts 2026 outlook after OneOncology-fueled earnings jump

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Simply Wall St 5d
Is Cencora Pricing Reflect Its DCF Upside After Recent Share Price Weakness

If you are wondering whether Cencora's current share price lines up with its underlying worth, it helps to look past the headline numbers and focus on what the...

Is Cencora Pricing Reflect Its DCF Upside After Recent Share Price Weakness

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.